Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00978289 · ClinicalTrials.gov registry record
Microenvironment of Adipose Tissue in Endocannabinoid System
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 20
- Enrollment target
NCT00978289 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 20 participants.
The verdict
NCT00978289 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is examine the relationship between adipose tissue inflammation and activation of the endocannabinoid system before and after Roux-en-Y gastric bypass surgery. The investigators hypothesize that the metabolic improvements and weight loss are due to mechanisms that antagonize the endocannabinoid system.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-07 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00978289
The ClinicalTrials.gov registry entry for NCT00978289 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00978289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00978289 about?
NCT00978289 is a clinical study titled "Microenvironment of Adipose Tissue in Endocannabinoid System". The purpose of this study is examine the relationship between adipose tissue inflammation and activation of the endocannabinoid system before and after Roux-en-Y gastric bypass surgery. The investigators hypothesize that the metabolic improvements and weight loss are due to mechanisms that antagoniz...
What is the current status of trial NCT00978289?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2008-07. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT00978289?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.